Trusted by leading research institutions
ScreenCell® is a patented microfiltration technology designed to enrich and recover circulating tumor cells (CTCs) and CTC clusters without immunological labeling from the whole blood of patients with solid tumors.
Explore the full range of ScreenCell® CTC isolation kits, each specifically designed to meet the diverse needs of liquid biopsy applications.
Blood draw
< 4 hours
Fixed CTCs
on the isolation support
Blood draw
4 hours > 3 days
Fixed CTCs
on the isolation support
Blood draw
4 hours > 3 days
Fixed CTCs
in suspension
or
Fixed CTCs
on microscope slide
Blood draw
< 4 hours
Fixed CTCs
in suspension
or
Fixed CTCs
on microscope slide
Blood draw
< 4 hours
Viable CTCs
on the isolation support
Blood draw
4 hours > 3 days
Fixed CTCs
on the isolation support
Blood draw
< 4 hours
Viable CTCs
in suspension
Blood draw
< 4 hours
Viable CTCs
on the isolation support
Blood draw
< 4 hours
Viable CTCs
in suspension
Scientific validation
We are transforming circulating tumor cell research into concrete solutions to improve cancer patient care.
Learn more about the French company that manufactures CTC isolation kits.
Discover our latest news and company culture through our various articles.
